Stratrix
On the Record · Hill-Rom Holdings

Hill-Rom Holdings acquisitions, on the record

The businesses Hill-Rom Holdings bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

BusinessDealWhenValue
Voalte
Word for word“In fiscal 2019, we completed the acquisition of Voalte for total aggregate consideration of $181.0 million, comprised of $175.8 million cash and $5.2 million of contingent consideration measured at fair value as of the acquisition date.” 10-K for 2019
acquisitionIn fiscal 2019total aggregate consideration of $181.0 million, comprised of $175.8 million cash and $5.2 million of contingent consideration measured at fair value as of the acquisition date
Breathe Technologies, Inc. ("Breathe")
Word for word“In fiscal 2019, we completed the acquisition of Breathe Technologies, Inc. (“Breathe”) for total aggregate cash consideration of $127.6 million .” 10-K for 2019
acquisitionIn fiscal 2019total aggregate cash consideration of $127.6 million
surgical consumable products business
Word for word“These uses of cash were offset by net proceeds of $166.6 million from the sale of certain of our surgical consumable products and related assets, as described in Note 3 of our Consolidated Financial Statements in Item 8 of this Form 10-K.” 10-K for 2019
divestiture—net proceeds of $166.6 million
third-party rental business
Word for word“Growth in the United States was partially offset by the divestiture of our third-party rental business in fiscal 2018 which contributed $12.2 million of Patient Support Systems revenue in fiscal 2018 and lower international revenue, specifically in Canada related to large capital projects that occurred in fiscal 2018.” 10-K for 2019
divestiturefiscal 2018$12.2 million of Patient Support Systems revenue in fiscal 2018
Mortara
Word for word“Net revenue increased 3.8% on a reported basis and 2.4% on a constant currency basis in fiscal 2018 compared to 2017 driven by growth in the United States.” 10-K for 2019
acquisition——
Excel Medical Electronics ("Excel Medical")
Word for word“Excel Medical Electronics (“Excel Medical”) Clinical communications software company located in the United States Purchased all of the outstanding equity interest.” 10-K for 2020
acquisition——
Connecta Soft, S.A. de C.V. ("Connecta")
Word for word“2020 Connecta Soft, S.A. de C.V. (“Connecta”) Clinical communications software company based in Mexico.” 10-K for 2020
acquisition——
Videomed
Word for word“Company Name Date of Acquisition Cash Paid Excel Medical January 10, 2020 $ 13.1 Connecta May 18, 2020 7.5 Videomed July 21, 2020 7.8 Fiscal 2020 Totals $ 28.4 Voalte April 1, 2019 $ 175.8 Breathe September 3, 2019 127.6 Fiscal 2019 Totals $ 303.4 37 Table of Contents Financing Activities Cash used in financing activities was $695.0 million for the fiscal year ended September 30, 2020 primarily driven by the repayment of the senior unsecured 5.75% notes of $425.0 million and related prepayment penalty of $12.2 million on October 7, 2019 with the net proceeds of the senior unsecured 4.375% notes issued in September 2019, as well as repayments of $270.0 million related to the Revolving Credit Facility during fiscal 2020.” 10-K for 2020
acquisitionJuly 21, 20207.8
Breathe
Word for word“Company Name Date of Acquisition Cash Paid Excel Medical January 10, 2020 $ 13.1 Connecta May 18, 2020 7.5 Videomed July 21, 2020 7.8 Fiscal 2020 Totals $ 28.4 Voalte April 1, 2019 $ 175.8 Breathe September 3, 2019 127.6 Fiscal 2019 Totals $ 303.4 37 Table of Contents Financing Activities Cash used in financing activities was $695.0 million for the fiscal year ended September 30, 2020 primarily driven by the repayment of the senior unsecured 5.75% notes of $425.0 million and related prepayment penalty of $12.2 million on October 7, 2019 with the net proceeds of the senior unsecured 4.375% notes issued in September 2019, as well as repayments of $270.0 million related to the Revolving Credit Facility during fiscal 2020.” 10-K for 2020
acquisitionSeptember 3, 2019127.6
Bardy Diagnostics, Inc.
Word for word“Acquisition of Bardy Diagnostics, Inc. As described in Note 3 to the consolidated financial statements, on August 6, 2021, the Company purchased all of the outstanding equity interest of Bardy Diagnostics, Inc.” 10-K for 2021
acquisitionAugust 6, 2021—
As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedCash paid for acquisitions (net of cash acquired)Goodwill from acquisitions
2016-09-30$25.3 million−$14.7 million
2017-09-30$311.4 million—
2018-09-30$0—
2019-09-30$303.4 million—
2020-09-30−$28.4 million—
2021-09-30$369 million—

Deal filings since 2016

Read from Hill-Rom Holdings’s annual reports (10-K for 2021, 10-K for 2020, 10-K for 2019) and the financial data it files with the SEC, as of 2021-11-12. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.